Effects of Plant Extract on Improving Minor Ailments: An Exploratory Study
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000041024
- Lead Sponsor
- Hokkaido Information University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1.Subjects who are under physician's advice, treatment, and/or medication for schizophrenia, depression, mania, neurological disorders, and/or sleep disorders. 2.Subjects with unusually high and/or low blood pressure and/or abnormal body measurement data and/or abnormal hematological data. 3.Subjects with severe anemia. 4.Subjects who are at risk of having allergic reactions to 28 food allergic substances or materials of test food. 5.Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 6.Pre- or post-menopausal women complaining of obvious physical changes. 7.Pregnant, lactating women or women who expect to be pregnant during this study. 8.Subjects who regularly eat which contains materials of test foods within 4 weeks, prior to the current study. 9.Subjects who regularly take medicine, functional foods, and/or supplements which would affect sleep and/or stress. 10.Subjects who plan to travel abroad during this study. 11.Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to the current study, or subjects who do not agree not to donate blood during this study. 12.Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study, or intend to participate in order clinical trials after obtaining consent to participate in this study. 13.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presenteeism
- Secondary Outcome Measures
Name Time Method Sleeping record, electroencephalogram during sleeping, heart rate variability, intestinal flora, urinary oxidative stress markers (8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-isoprostane), survey on subjects' sleeping and mental and physical conditions.